Global Epidemiological Impact of PNPLA3 I148M on Liver Disease
Open Access
- 7 October 2024
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 45 (3)
Abstract
The prevalence of metabolic dysfunction‐associated steatotic liver disease (MASLD) has increased exponentially over the past three decades, in parallel with the global rise in obesity and type 2 diabetes. It is currently the most common cause of liver‐related morbidity and mortality. Although obesity has been identified as a key factor in the increased prevalence of MASLD, individual differences in susceptibility are significantly influenced by genetic factors. PNPLA3 I148M (rs738409 C>G) is the variant with the greatest impact on the risk of developing progressive MASLD and likely other forms of steatotic liver disease. This variant is prevalent across the globe, with the risk allele (G) frequency exhibiting considerable variation. Here, we review the contribution of PNPLA3 I148M to global burden and regional differences in MASLD prevalence, focusing on recent evidence emerging from population‐based sequencing studies and prevalence assessments. We calculated the population attributable fraction (PAF) as a means of quantifying the impact of the variant on MASLD. Furthermore, we employ quantitative trait locus (QTL) analysis to ascertain the associations between rs738409 and a range of phenotypic traits. This analysis suggests that these QTLs may underpin pleiotropic effects on extrahepatic traits. Finally, we outline potential avenues for further research and identify key areas for investigation in future studies.Keywords
This publication has 65 references indexed in Scilit:
- Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General PopulationHepatology, 2020
- Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisHepatology, 2019
- The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damageHepatology, 2015
- Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant dataHepatology, 2013
- Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis BHepatology, 2013
- Characterization of European Ancestry Nonalcoholic Fatty Liver Disease-Associated Variants in Individuals of African And Hispanic DescentHepatology, 2013
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver diseaseHepatology, 2011
- Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C σHepatology, 2010
- Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasiansHepatology, 2010
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004